Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs. HFpEF Presented

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - AstraZenca; Sensible Medical; Volumetrix</li><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Alleviant Medical; AstraZenca; Boehringer Ingelheim; Boston Scientific Corporation; CVRx; Edwards Lifesciences; Impluse Dynamics; V-Wave</li></ul>